FILE PHOTO: Signage is seen outside of the Food and Drug Administration  headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo

The United States Food and Drug Administration proposed revoking approval for Salerno Pharmaceuticals' liquid cholesterol medication on Tuesday afternoon. The regulatory action targets the drug FloLipid over missing mandatory disclosures.